Table of Content

Executive Summary
1 Product Definition
1.1 Ventricular Assist Devices
1.2 Total Artificial Heart

2 Scope of the Report

3 Research Methodology
3.1 Research Methodology

4 Industry Analysis
4.1 Industry Structure
4.2 Value Chain Analysis
4.3 Regulatory Framework
4.3.1 Regulatory Framework in America
4.3.2 Regulatory Framework in Europe
4.3.1 Regulatory Framework in Asia-Pacific
4.4 Patent Analysis

5 Competitive Landscape
5.1 Vendor Share Analysis
5.2 Key Developments and Strategies
5.2.1 Funding
5.2.2 Product Approvals
5.2.3 Mergers and Acquisitions
5.2.4 Agreements, Partnerships, and Collaborations
5.2.5 Other Strategies

6 Market Dynamics
6.1 Market Drivers
6.1.1 Growing Geriatric Population
6.1.2 Rising Incidence of Lifestyle Diseases
6.1.3 Increasing Need of Organ Transplantation and Deadly Shortage of Available Donors
6.1.4 Persistent Support from Government and Non-Governmental Organizations
6.1.5 Technological Advancements and Increased R&D Expenditure
6.2 Challenges
6.2.1 Risks of Device Malfunction and Other Related Concerns
6.2.2 Immune Barrier to Artificial Organ
6.2.3 Stringent Regulation and Poor Reimbursement Coverage
6.2.4 Exorbitant Cost of Product
6.3 Opportunities
6.3.1 Application of Advanced Biomaterials in Artificial Organs
6.3.2 Organ-on-chips Technology

7 Global Ventricular Assist Devices and Total Artificial Heart Market (Product)
7.1 Overview
7.2 Assumptions and Limitations
7.3 Ventricular Assist Devices
7.3.1 Components of a VAD
7.3.2 Types of VAD
7.3.3 Timeline
7.3.4 Left Ventricular Assist Device
7.3.5 Right Ventricular Assist Device
7.3.6 Bi-Ventricular Assist Device
7.4 Total Artificial Heart
7.4.1 Timeline

8 Global Ventricular Assist Devices and Total Artificial Heart Market (Distribution Channels)
8.1 Overview
8.2 Hospitals
8.3 Cardiology Clinics

9 Global Ventricular Assist Devices and Total Artificial Heart Market (by Region)
9.1 Overview
9.1.1 Analysis of Growth Potential of Different Countries
9.2 North America
9.2.1 The U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 The U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Sweden
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 Australia
9.4.4 India
9.5 Rest-of-the-World
9.5.1 Latin America
9.5.2 Middle East and Africa

10 Company Profiles
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Overview
10.2.2 Role of Abbott Laboratories in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 ABIOMED
10.3.1 Overview
10.3.2 Role of ABIOMED in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Berlin Heart
10.4.1 Overview
10.4.2 Role of Berlin Heart in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.4.3 Key Developments
10.4.4 SWOT Analysis
10.5 BiVACOR
10.5.1 Overview
10.5.2 Role of BiVACOR in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.5.3 Key Development
10.5.4 SWOT Analysis
10.6 CARMAT
10.6.1 Overview
10.6.2 Role of CARMAT in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.6.3 Key Developments
10.6.4 SWOT Analysis
10.7 Jarvik Heart Inc.
10.7.1 Overview
10.7.2 Role of Jarvik Heart Inc. in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.7.3 SWOT Analysis
10.8 Sun Medical Technology Research Institute, Inc.
10.8.1 Overview
10.8.2 Role of Sun Medical Technology Research Institute in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.8.3 Key Developments
10.8.4 SWOT Analysis
10.9 LivaNova PLC
10.9.1 Overview
10.9.2 Role of LivaNova PLC in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.9.3 Key Developments
10.9.4 Financials
10.9.4.1 Key Insights About Financial Health of the Company
10.9.5 SWOT Analysis
10.10 Medtronic PLC
10.10.1 Overview
10.10.2 Role of Medtronic PLC in the Global Ventricular Assist Devices and Total Artificial Heart Market
10.10.3 Financials
10.10.3.1 Key Insights about Financial Health of the Company
10.10.4 SWOT Analysis
10.11 SynCardia Systems, LLC
10.11.1 Overview
10.11.2 Role of Syncardia Systems, LLC in the Ventricular Assist Devices and Total Artificial Heart Market
10.11.3 Key Developments
10.11.4 SWOT Analysis
 



List of Tables



Table 4.1: Regulatory Authorities/Associations/Consortiums for Medical Devices in America
Table 4.2: Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
Table 4.3: Regulatory Authorities/Associations/Consortiums for Medical Devices in Asia-Pacific
Table 6.1: Percentage of Total Regional Population Aged 65 Years: 2015 & 2030
Table 6.2: Contribution of Risk Factors to Lifestyle Diseases (Percentage of Individual Population Attributable Fraction)
Table 6.3: Disease Burden Due to Common Lifestyle Diseases Across Different Regions (2016)
Table 6.4: Funding Initiatives by Private and Public Companies
Table 6.5: Post-Operational Consequences of SynCardia TAH Implantation
Table 6.6: Post-Operational Consequences of Total Artificial Heart (TAH) Implantation
Table 7.1: Timeline- Ventricular Assist Devices
Table 7.2: Timeline- Total Artificial Heart

List of Figures

Figure 1: Evolution of VAD and Artificial Heart
Figure 2: Market Statistics
Figure 3: Impact of Market Drivers and Market Restraints (2018)
Figure 4: Global VAD and TAH Market Size, By Product, 2018
Figure 5: Share of Key Strategies and Development, January 2014-March 2019
Figure 6: Market Share Analysis for the Global Ventricular Assist Devices and Total Artificial Heart Market, 2018
Figure 2.1: Global Ventricular Assist Devices and Total Artificial Heart: Market Segmentation
Figure 3.1: Ventricular Assist Devices and Total Artificial Heart Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-Up Approach (Segment-wise Analysis)
Figure 3.6: Assumptions and Limitations
Figure 3.7: Factors Considered for Data Prediction and Modeling
Figure 4.1: Value Analysis of Ventricular Assist Devices and Total Artificial Heart Market
Figure 4.2: Patent Analysis for the Global Ventricular Assist Devices and Total Artificial Heart Market
Figure 4.3: Patent Timeline in the Global Ventricular Assist Devices and Total Artificial Heart Market
Figure 5.1: Competitive Landscape- Global Ventricular Assist Devices and Total Artificial Heart Market
Figure 5.2: Market Share Analysis for the Global Ventricular Assist Devices and Total Artificial Heart Market, 2018
Figure 5.3: Market Share Analysis for the Global Ventricular Assist Devices Market, 2018
Figure 5.4: Market Share Analysis for the Global Total Artificial Heart Market, 2018
Figure 5.5: Share of Key Developments and Strategies, January 2014-March 2019
Figure 5.6: Funding Activities Share (by Companies), January 2014-February 2019
Figure 5.7: Product Approval Share (by Companies), January 2014-February 2019
Figure 6.1: Projected Global Geriatric Population Aged 60 Years (in billion), 1900-2100
Figure 6.2: Number of Donors Recovered and Patients Waiting at the Year-end VS Number of Transplants Performed (2010-2017)
Figure 7.1: Global VAD and TAH Market, by Product, Market Share 2018
Figure 7.2: Global Left Ventricular Assist Devices Market, 2018-2023
Figure 7.3: Global Right Ventricular Assist Device Market, 2018-2023
Figure 7.4: Global Bi-Ventricular Assist Devices Market, 2018-2023
Figure 7.5: Mechanism of Action of TAH
Figure 7.6: Key Points about AbioCor
Figure 7.7: Global Total Artificial Heart Market, 2018-2023
Figure 7.8: Sales of SynCardia System, LLC’s TAH (by Volume), 2009-2023
Figure 8.1: Global Ventricular Assist Devices and Total Artificial Heart Market, by Distribution Channel, Market Share 2018
Figure 8.2: Hospitals in the Global Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 8.3: Cardiology Clinics in the Global Ventricular Assist Devices and Total Artificial Heart Market, 2018-2028
Figure 9.1: Global Ventricular Assist Device and Total Artificial Heart Market by Region, Market Share, 2018
Figure 9.2: North America: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 9.3: North America: Market Dynamics
Figure 9.4: Number of Donors Recovered and Transplants Performed per Year VS Patients Waiting at the Year End
Figure 9.5: Europe: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 9.6: Europe: Market Dynamics
Figure 9.7: Asia-Pacific: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 9.8: Asia-Pacific: Market Dynamics
Figure 9.9: Rest-of-the-World: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 9.10: Rest-of-the-World: Market Dynamics
Figure 9.11: Latin-America: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 9.12: Middle-East and Africa: Ventricular Assist Devices and Total Artificial Heart Market, 2018-2023
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.3: Abbott Laboratories, By Segment, 2016-2018
Figure 10.4: Abbott Laboratories, By Region, 2016-2018
Figure 10.5: Abbott Laboratories: SWOT Analysis
Figure 10.6: ABIOMED: Overall Financials, 2016-2018
Figure 10.7: ABIOMED, By Segment, 2016-2018
Figure 10.8: ABIOMED, R&D Expenditure, 2017-2018
Figure 10.9: ABIOMED: SWOT Analysis
Figure 10.10: Berlin Heart: SWOT Analysis
Figure 10.11: BiVACOR: SWOT Analysis
Figure 10.12: CARMAT: SWOT Analysis
Figure 10.13: Jarvik Heart Inc.: SWOT Analysis
Figure 10.14: Sun Medical Technology Research Institute Inc.: SWOT Analysis
Figure 10.15: LivaNova PLC: Overall Product Portfolio
Figure 10.16: LivaNova PLC: Overall Financials, 2016-2018
Figure 10.17: LivaNova PLC (by Segment), 2016-2018
Figure 10.18: LivaNova PLC: Revenue (by Region), 2016-2018
Figure 10.19: LivaNova PLC: Revenue for Advanced Circulatory Support (by Region), 2016-2018
Figure 10.20: LivaNova PLC: R&D Expenditure, 2016-2018
Figure 10.21: LivaNova PLC: SWOT Analysis
Figure 10.22: Medtronic PLC: Overall Financials, 2016-2018
Figure 10.23: Medtronic PLC: Revenue (by Segment), 2016-2018
Figure 10.24: Medtronic PLC: Revenue (by Region), 2016-2018
Figure 10.25: Medtronic PLC: R&D Expenditure
Figure 10.26: Medtronic PLC: SWOT Analysis
Figure 10.27: SynCardia Systems, LLC Product Portfolio for Ventricular Assist Devices and Total Artificial Heart Market
Figure 10.28: SynCardia Systems, LLC: SWOT Analysis